Health News

Precision Health: A Global Call to Action

Precision health is advancing at extraordinary speed, reshaping how we predict illness, diagnose disease, and tailor treatment. With gene sequencing costs falling from £2 billion to £230 in just two decades and AI now analysing complex multi-omic data, the potential for personalised, effective care has never been greater. But as the Global Impact Committee’s latest report makes clear, this progress risks deepening inequity unless global systems act now. The GIC – an independent advisory board supporting Beamtree’s mission to mobilise the power of data for a healthier, happier world – examines both the opportunity and the challenge. As the report states, “The impact of precision health will be as great as medical landmarks such as the discovery of antibiotics and advances in imaging technology.” Yet services remain concentrated in major cities, therapies can cost more than £1.5 million per patient, and entire regions such as Africa, home to 19% of the global population but less than 2% of genetic datasets, are at risk of being left behind. Beamtree CEO Marek Stepniak emphasises why this work matters: “Precision health represents one of the most profound shifts in modern healthcare. But its true value will only be realised if every community, not just the privileged few, can access the benefits. This report outlines the actions and collaborations needed to ensure precision health becomes equitable, sustainable, and safe at scale.”  The report calls for coordinated action across governments, regulators, and healthcare systems – reforms that can make precision health accessible, trustworthy, and truly global. Its message is clear: innovation alone won’t deliver better outcomes; equitable access will. Read the full report here to explore the insights and recommendations shaping the future of precision health.